Liyan Sun

Title: Liyan Sun: Innovator in Blood Group Genotyping

Introduction

Liyan Sun is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of blood group genotyping, particularly through his innovative methods and kits that utilize next-generation sequencing technology.

Latest Patents

Liyan Sun holds a patent for a "Method and kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS)." This invention provides a method and kit that enable the rapid genotyping of 17 RBC blood group systems and multiple key rare blood groups. The technology employs multiplex PCR capture primer sets and amplification reaction conditions designed for the Illumina platform. This allows for the simultaneous detection of full-length coding regions and spliced flanking regions of 25 blood group genes across three reactions. The method boasts high detection efficiency and low average costs, overcoming limitations of existing blood group gene detection technologies.

Career Highlights

Liyan Sun is affiliated with the Shenzhen Blood Center, where he applies his expertise in blood group genotyping. His work has been instrumental in advancing the capabilities of blood group gene detection, providing comprehensive and accurate results that include both known and unknown mutation sites.

Collaborations

Liyan collaborates with notable colleagues, including Shuang Liang and Jinfeng Zeng, who contribute to the research and development efforts at the Shenzhen Blood Center.

Conclusion

Liyan Sun's innovative work in blood group genotyping represents a significant advancement in medical technology. His contributions not only enhance the efficiency of blood group detection but also pave the way for future innovations in the field.